211 related articles for article (PubMed ID: 23873128)
1. Effects on glucagon-like peptide-1 secretion by distal ileal administration of nutrients.
Feng X; Zhong S; Yang J; Wang Y; Liu J
Obes Surg; 2013 Nov; 23(11):1774-82. PubMed ID: 23873128
[TBL] [Abstract][Full Text] [Related]
2. Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor.
Sun X; Zheng M; Song M; Bai R; Cheng S; Xing Y; Yuan H; Wang P
Int J Clin Exp Pathol; 2014; 7(7):4136-42. PubMed ID: 25120793
[TBL] [Abstract][Full Text] [Related]
3. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
[TBL] [Abstract][Full Text] [Related]
4. Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.
Han H; Wang L; Du H; Jiang J; Hu C; Zhang G; Liu S; Zhang X; Liu T; Hu S
Obes Surg; 2015 Oct; 25(10):1802-9. PubMed ID: 25726319
[TBL] [Abstract][Full Text] [Related]
5. Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.
Chai J; Zhang G; Liu S; Hu C; Han H; Hu S; Zhang Z
Obes Surg; 2016 Feb; 26(2):261-8. PubMed ID: 26024737
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery.
Oh TJ; Ahn CH; Cho YM
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):94-101. PubMed ID: 27186363
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
[TBL] [Abstract][Full Text] [Related]
8. Dual effect of RYGB on the entero-insular axis: How GLP-1 is enhanced by surgical duodenal exclusion.
Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Mateo-Gavira I; Castro-Santiago MJ; Casar-García J; Prada-Oliveira JA
Ann Anat; 2023 Aug; 249():152094. PubMed ID: 37011826
[TBL] [Abstract][Full Text] [Related]
9. Myocardial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats after ileal transposition.
Yan Z; Chen W; Liu S; Zhang G; Sun D; Hu S
Obes Surg; 2012 Mar; 22(3):493-501. PubMed ID: 22249887
[TBL] [Abstract][Full Text] [Related]
10. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.
Layer P; Holst JJ; Grandt D; Goebell H
Dig Dis Sci; 1995 May; 40(5):1074-82. PubMed ID: 7729267
[TBL] [Abstract][Full Text] [Related]
11. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection.
Bendet N; Scapa E; Cohen O; Bloch O; Aharoni D; Ramot Y; Weiss M; Halevi A; Rapoport MJ
Scand J Gastroenterol; 2004 Jul; 39(7):650-6. PubMed ID: 15370686
[TBL] [Abstract][Full Text] [Related]
13. Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus.
Weng SG; Zhang B; Wang X; Chen H
Obes Surg; 2017 Aug; 27(8):2067-2072. PubMed ID: 28233263
[TBL] [Abstract][Full Text] [Related]
14. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
[TBL] [Abstract][Full Text] [Related]
15. The Impacts of Gastroileostomy Rat Model on Glucagon-like Peptide-1: a Promising Model to Control Type 2 Diabetes Mellitus.
Keleidari B; Mohammadi Mofrad R; Shahabi Shahmiri S; Sanei MH; Kolahdouzan M; Sheikhbahaei E
Obes Surg; 2018 Oct; 28(10):3246-3252. PubMed ID: 29785472
[TBL] [Abstract][Full Text] [Related]
16. Expression of sweet taste receptor and gut hormone secretion in modelled type 2 diabetes.
Feng R; Qian C; Liu Q; Jin Y; Liu L; Li S; Liao Y; Zhou H; Liu W; Rayner CK; Ma J
Gen Comp Endocrinol; 2017 Oct; 252():142-149. PubMed ID: 28782537
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
Quddusi S; Vahl TP; Hanson K; Prigeon RL; D'Alessio DA
Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
[TBL] [Abstract][Full Text] [Related]
18. Blockade of Central GLP-1 Receptors Deteriorates the Improvement of Diabetes after Ileal Transposition.
Chen W; Xu Q; Xiao Y; Zhou J; Zhang W; Lin G; Gong F
Int J Med Sci; 2016; 13(12):955-962. PubMed ID: 27994501
[No Abstract] [Full Text] [Related]
19. Diet-induced obesity enhances postprandial glucagon-like peptide-1 secretion in Wistar rats, but not in diabetic Goto-Kakizaki rats.
Pinyo J; Hara H; Hira T
Br J Nutr; 2021 Aug; 126(4):518-530. PubMed ID: 33143769
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
